Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.

ABSTRACT:

SUBMITTER: Jeon JH 

PROVIDER: S-EPMC12523003 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature